The Urine Biomarker PUR-4 Is Positively Associated with the Amount of Gleason 4 in Human Prostate Cancers
The Prostate Urine Risk (PUR) biomarker is a four-group classifier for predicting outcome in patients prior to biopsy and for men on active surveillance. The four categories correspond to the probabilities of the presence of normal tissue (PUR-1), D’Amico low-risk (PUR-2), intermediate-risk (PUR-3),...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-11-01
|
| Series: | Life |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-1729/11/11/1172 |
| _version_ | 1797509677924220928 |
|---|---|
| author | Richard Y. Ball Ryan Cardenas Mark S. Winterbone Marcelino Y. Hanna Chris Parker Rachel Hurst Daniel S. Brewer Lauren D’Sa Rob Mills Colin S. Cooper Jeremy Clark |
| author_facet | Richard Y. Ball Ryan Cardenas Mark S. Winterbone Marcelino Y. Hanna Chris Parker Rachel Hurst Daniel S. Brewer Lauren D’Sa Rob Mills Colin S. Cooper Jeremy Clark |
| author_sort | Richard Y. Ball |
| collection | DOAJ |
| description | The Prostate Urine Risk (PUR) biomarker is a four-group classifier for predicting outcome in patients prior to biopsy and for men on active surveillance. The four categories correspond to the probabilities of the presence of normal tissue (PUR-1), D’Amico low-risk (PUR-2), intermediate-risk (PUR-3), and high-risk (PUR-4) prostate cancer. In the current study we investigate how the PUR-4 status is linked to Gleason grade, prostate volume, and tumor volume as assessed from biopsy (<i>n</i> = 215) and prostatectomy (<i>n</i> = 9) samples. For biopsy data PUR-4 status alone was linked to Gleason Grade group (GG) (Spearman’s, <i>ρ</i> = 0.58, <i>p</i> < 0.001 trend). To assess the impact of tumor volume each GG was dichotomized into Small and Large volume cancers relative to median volume. For GG1 (Gleason Pattern 3 + 3) cancers volume had no impact on PUR-4 status. In contrast for GG2 (3 + 4) and GG3 (4 + 3) cancers PUR-4 levels increased in large volume cancers with statistical significance observed for GG2 (<i>p</i> = 0.005; Games-Howell). These data indicated that PUR-4 status is linked to the presence of Gleason Pattern 4. To test this observation tumor burden and Gleason Pattern were assessed in nine surgically removed and sectioned prostates allowing reconstruction of 3D maps. PUR-4 was not correlated with Gleason Pattern 3 amount, total tumor volume or prostate size. A strong correlation was observed between amount of Gleason Pattern 4 tumor and PUR-4 signature (<i>r</i> = 0.71, <i>p</i> = 0.034, Pearson’s). These observations shed light on the biological significance of the PUR biomarker and support its use as a non-invasive means of assessing the presence of clinically significant prostate cancer. |
| first_indexed | 2024-03-10T05:21:08Z |
| format | Article |
| id | doaj.art-da05f8c2ac47466c831676bc9de0f325 |
| institution | Directory Open Access Journal |
| issn | 2075-1729 |
| language | English |
| last_indexed | 2024-03-10T05:21:08Z |
| publishDate | 2021-11-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Life |
| spelling | doaj.art-da05f8c2ac47466c831676bc9de0f3252023-11-23T00:03:54ZengMDPI AGLife2075-17292021-11-011111117210.3390/life11111172The Urine Biomarker PUR-4 Is Positively Associated with the Amount of Gleason 4 in Human Prostate CancersRichard Y. Ball0Ryan Cardenas1Mark S. Winterbone2Marcelino Y. Hanna3Chris Parker4Rachel Hurst5Daniel S. Brewer6Lauren D’Sa7Rob Mills8Colin S. Cooper9Jeremy Clark10Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich NR4 7UY, UKNorwich Medical School, University of East Anglia, Norwich NR4 7TJ, UKNorwich Medical School, University of East Anglia, Norwich NR4 7TJ, UKUrology Department Castle Hill, Hull University Teaching Hospital, Castle Rd, Cottingham HU16 5JQ, UKInstitute of Cancer Research, Sutton SM2 5NG, UKNorwich Medical School, University of East Anglia, Norwich NR4 7TJ, UKNorwich Medical School, University of East Anglia, Norwich NR4 7TJ, UKNorfolk and Norwich University Hospitals NHS Foundation Trust, Norwich NR4 7UY, UKNorfolk and Norwich University Hospitals NHS Foundation Trust, Norwich NR4 7UY, UKNorwich Medical School, University of East Anglia, Norwich NR4 7TJ, UKNorwich Medical School, University of East Anglia, Norwich NR4 7TJ, UKThe Prostate Urine Risk (PUR) biomarker is a four-group classifier for predicting outcome in patients prior to biopsy and for men on active surveillance. The four categories correspond to the probabilities of the presence of normal tissue (PUR-1), D’Amico low-risk (PUR-2), intermediate-risk (PUR-3), and high-risk (PUR-4) prostate cancer. In the current study we investigate how the PUR-4 status is linked to Gleason grade, prostate volume, and tumor volume as assessed from biopsy (<i>n</i> = 215) and prostatectomy (<i>n</i> = 9) samples. For biopsy data PUR-4 status alone was linked to Gleason Grade group (GG) (Spearman’s, <i>ρ</i> = 0.58, <i>p</i> < 0.001 trend). To assess the impact of tumor volume each GG was dichotomized into Small and Large volume cancers relative to median volume. For GG1 (Gleason Pattern 3 + 3) cancers volume had no impact on PUR-4 status. In contrast for GG2 (3 + 4) and GG3 (4 + 3) cancers PUR-4 levels increased in large volume cancers with statistical significance observed for GG2 (<i>p</i> = 0.005; Games-Howell). These data indicated that PUR-4 status is linked to the presence of Gleason Pattern 4. To test this observation tumor burden and Gleason Pattern were assessed in nine surgically removed and sectioned prostates allowing reconstruction of 3D maps. PUR-4 was not correlated with Gleason Pattern 3 amount, total tumor volume or prostate size. A strong correlation was observed between amount of Gleason Pattern 4 tumor and PUR-4 signature (<i>r</i> = 0.71, <i>p</i> = 0.034, Pearson’s). These observations shed light on the biological significance of the PUR biomarker and support its use as a non-invasive means of assessing the presence of clinically significant prostate cancer.https://www.mdpi.com/2075-1729/11/11/1172prostatecancerurinePURPUR-4Gleason pattern 4 |
| spellingShingle | Richard Y. Ball Ryan Cardenas Mark S. Winterbone Marcelino Y. Hanna Chris Parker Rachel Hurst Daniel S. Brewer Lauren D’Sa Rob Mills Colin S. Cooper Jeremy Clark The Urine Biomarker PUR-4 Is Positively Associated with the Amount of Gleason 4 in Human Prostate Cancers Life prostate cancer urine PUR PUR-4 Gleason pattern 4 |
| title | The Urine Biomarker PUR-4 Is Positively Associated with the Amount of Gleason 4 in Human Prostate Cancers |
| title_full | The Urine Biomarker PUR-4 Is Positively Associated with the Amount of Gleason 4 in Human Prostate Cancers |
| title_fullStr | The Urine Biomarker PUR-4 Is Positively Associated with the Amount of Gleason 4 in Human Prostate Cancers |
| title_full_unstemmed | The Urine Biomarker PUR-4 Is Positively Associated with the Amount of Gleason 4 in Human Prostate Cancers |
| title_short | The Urine Biomarker PUR-4 Is Positively Associated with the Amount of Gleason 4 in Human Prostate Cancers |
| title_sort | urine biomarker pur 4 is positively associated with the amount of gleason 4 in human prostate cancers |
| topic | prostate cancer urine PUR PUR-4 Gleason pattern 4 |
| url | https://www.mdpi.com/2075-1729/11/11/1172 |
| work_keys_str_mv | AT richardyball theurinebiomarkerpur4ispositivelyassociatedwiththeamountofgleason4inhumanprostatecancers AT ryancardenas theurinebiomarkerpur4ispositivelyassociatedwiththeamountofgleason4inhumanprostatecancers AT markswinterbone theurinebiomarkerpur4ispositivelyassociatedwiththeamountofgleason4inhumanprostatecancers AT marcelinoyhanna theurinebiomarkerpur4ispositivelyassociatedwiththeamountofgleason4inhumanprostatecancers AT chrisparker theurinebiomarkerpur4ispositivelyassociatedwiththeamountofgleason4inhumanprostatecancers AT rachelhurst theurinebiomarkerpur4ispositivelyassociatedwiththeamountofgleason4inhumanprostatecancers AT danielsbrewer theurinebiomarkerpur4ispositivelyassociatedwiththeamountofgleason4inhumanprostatecancers AT laurendsa theurinebiomarkerpur4ispositivelyassociatedwiththeamountofgleason4inhumanprostatecancers AT robmills theurinebiomarkerpur4ispositivelyassociatedwiththeamountofgleason4inhumanprostatecancers AT colinscooper theurinebiomarkerpur4ispositivelyassociatedwiththeamountofgleason4inhumanprostatecancers AT jeremyclark theurinebiomarkerpur4ispositivelyassociatedwiththeamountofgleason4inhumanprostatecancers AT richardyball urinebiomarkerpur4ispositivelyassociatedwiththeamountofgleason4inhumanprostatecancers AT ryancardenas urinebiomarkerpur4ispositivelyassociatedwiththeamountofgleason4inhumanprostatecancers AT markswinterbone urinebiomarkerpur4ispositivelyassociatedwiththeamountofgleason4inhumanprostatecancers AT marcelinoyhanna urinebiomarkerpur4ispositivelyassociatedwiththeamountofgleason4inhumanprostatecancers AT chrisparker urinebiomarkerpur4ispositivelyassociatedwiththeamountofgleason4inhumanprostatecancers AT rachelhurst urinebiomarkerpur4ispositivelyassociatedwiththeamountofgleason4inhumanprostatecancers AT danielsbrewer urinebiomarkerpur4ispositivelyassociatedwiththeamountofgleason4inhumanprostatecancers AT laurendsa urinebiomarkerpur4ispositivelyassociatedwiththeamountofgleason4inhumanprostatecancers AT robmills urinebiomarkerpur4ispositivelyassociatedwiththeamountofgleason4inhumanprostatecancers AT colinscooper urinebiomarkerpur4ispositivelyassociatedwiththeamountofgleason4inhumanprostatecancers AT jeremyclark urinebiomarkerpur4ispositivelyassociatedwiththeamountofgleason4inhumanprostatecancers |